Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial | Zendy

Haiyan Zhang | Zendy; Zhiping Fan | Zendy; Fen Huang | Zendy; Lijie Han | Zendy; Yajing Xu | Zendy; Na Xu | Zendy; Lan Deng | Zendy; Shunqing Wang | Zendy; Dongjun Lin | Zendy; Xiaodan Luo | Zendy; Qing Zhang | Zendy; Xiaodan Liu | Zendy; Xudong Li | Zendy; Xinquan Liang | Zendy; Shuangfeng Xie | Zendy; Hong Qu | Zendy; Sijian Yu | Zendy; Hongsheng Zhou | Zendy; Pengcheng Shi | Zendy; Li Xuan | Zendy; Ren Lin | Zendy; Hui Liu | Zendy; Hua Jin | Zendy; Jing Sun | Zendy; Qifa Liu | Zendy

Open Access

Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

Author(s) -

Haiyan Zhang,

Zhiping Fan,

Fen Huang,

Lijie Han,

Yajing Xu,

Na Xu,

Lan Deng,

Shunqing Wang,

Dongjun Lin,

Xiaodan Luo,

Qing Zhang,

Xiaodan Liu,

Xudong Li,

Xinquan Liang,

Shuangfeng Xie,

Hong Qu,

Sijian Yu,

Hongsheng Zhou,

Pengcheng Shi,

Li Xuan,

Ren Lin,

Hui Liu,

Hua Jin,

Jing Sun,

Qifa Liu

Publication year - 2022

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.22.00767

Subject(s) - medicine , busulfan , cyclophosphamide , total body irradiation , hematopoietic stem cell transplantation , clinical endpoint , surgery , gastroenterology , transplantation , chemotherapy , clinical trial

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research